Arabesque Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Arabesque Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-61,677	Closed	-$4.44M	–	19
2022 Q4	$4.44M	Buy	61,677 +20,212	+49%	+$1.52M	1.5%	10
2022 Q3	$2.95M	Buy	41,465 +12,194	+42%	+$885K	1.44%	10
2022 Q2	$2.25M	Buy	29,271 +18,300	+167%	+$1.39M	1.19%	14
2022 Q1	$801K	Buy	+10,971	New	+$737K	0.28%	114

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Arabesque Asset Management's BMY Position: Q1 2023 in Review

Arabesque Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 61,677 shares — an estimated $4.44M sold.

Arabesque Asset Management first reported a position in BMY in Q1 2022 and held it in 4 quarters. The position peaked at $4.44M in Q4 2022. 2,542 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

Arabesque Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
Arabesque Asset Management sold 61,677 Bristol-Myers Squibb shares in Q1 2023, an estimated $4.44M.
Arabesque Asset Management first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 4 quarters.
Arabesque Asset Management's Bristol-Myers Squibb position peaked at $4.44M in Q4 2022.
2,542 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on Arabesque Asset Management's 13F filing for Q1 2023.